DarioHealth ( NASDAQ: DRIO ), a leader in the global digital health market, today announced a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. The move reflects Dario's commitment to bringing its innovative solutions to the market faster, maximizing customer impact, and driving the organization to profitability. To achieve this goal, DarioHealth is implementing a new organizational model. The president role will be eliminated, and dedicated C-level positions will be established for each core function, reporting directly to the chief executive officer. The newly created role of chief commercial officer ("CCO") will be in addition to the existing C-Level roles. Further strengthening its commercial focus, DarioHealth announced the appointment of Steven Nelson as its CCO. "We are excited to welcome Steven as DarioHealth's chief commercial officer.